UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

En dos antibiotika lika effektiv vid bröstimplantatkirurgi

Läkartidningen, 2023-04, Vol.120

2023

Volltextzugriff (PDF)

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

BMC cancer, 2017, Vol.17 (1), p.379-379, Article 379

2017

Volltextzugriff (PDF)

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy

Breast cancer research and treatment, 2022-06, Vol.193 (3), p.589-595

2022

Volltextzugriff (PDF)

Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial

PloS one, 2022-10, Vol.17 (10), p.e0274804-e0274804

2022

Volltextzugriff (PDF)

High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes

PloS one, 2013-02, Vol.8 (2), p.e56795-e56795

2013

Volltextzugriff (PDF)

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial

Breast (Edinburgh), 2022-06, Vol.63, p.16-23

2022

Volltextzugriff (PDF)

Breast Cancer Survival in Relation to the Metastatic Tumor Burden in Axillary Lymph Nodes

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2868-2873

2010

Volltextzugriff (PDF)

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

Breast cancer research and treatment, 2020-02, Vol.180 (1), p.167-176

2020

Volltextzugriff (PDF)

3370: Is less axillary surgery safe in irradiated, high-risk breast cancer patients: Results from the SENOMAC trial

Radiotherapy and oncology, 2024-05, Vol.194, p.S56-S57

de Boniface, Jana

2024

Volltextzugriff (PDF)

Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases – an open, multicentre, randomised non-inferiority phase 3 trial

BMJ open, 2023, Vol.13 (9), p.e075543-e075543

2023

Volltextzugriff (PDF)

Which real indications remain for mastectomy?

Lancet Regional Health - Americas (Online), 2024-05, Vol.33, p.100734-100734, Article 100734

2024

Volltextzugriff (PDF)

Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients

Oncoimmunology, 2012-11, Vol.1 (8), p.1305-1312

2012

Volltextzugriff (PDF)

Immediate Breast Reconstruction

Breast care (Basel, Switzerland), 2020-04, Vol.15 (2), p.188-191

2020

Volltextzugriff (PDF)

Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women

JAMA surgery, 2021-07, Vol.156 (7), p.628

2021

Volltextzugriff (PDF)

Patients’ experiences of axillary surgery in the randomized SENOMAC trial: a focus group study

European journal of surgical oncology, 2024-02, Vol.50 (2), p.107446, Article 107446

2024

Volltextzugriff (PDF)

Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women

British journal of surgery, 2022-09, Vol.109 (10), p.977-983

2022

Volltextzugriff (PDF)

Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy

Geburtshilfe und Frauenheilkunde, 2021-10, Vol.81 (10), p.1121-1127

2021

Volltextzugriff (PDF)

Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant

Breast cancer research and treatment, 2019-04, Vol.174 (3), p.795-805

2019

Volltextzugriff (PDF)

CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment

The Journal of clinical investigation, 2020-03, Vol.130 (3), p.1185-1198

2020

Volltextzugriff (PDF)

Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom

TumorDiagnostik & Therapie, 2022-04, Vol.43 (3), p.197-203

2022

Volltextzugriff (PDF)

Medical and surgical postoperative complications after breast conservation versus mastectomy in older women with breast cancer: Swedish population-based register study of 34 139 women

British journal of surgery, 2023-02, Vol.110 (3), p.344-352

2023

Volltextzugriff (PDF)

Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom

Senologie (Stuttgart), 2022-03, Vol.19 (1), p.49-55

2022

Volltextzugriff (PDF)

Abstract P1-01-16: Perspectives on axillary management after primary systemic treatment: An international EUBREAST survey

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-01-16

2022

Volltextzugriff (PDF)

Axillary staging in node-positive breast cancer converting to node negativity through neoadjuvant chemotherapy: Current evidence and perspectives

Scandinavian Journal of Surgery, 2023-06, Vol.112 (2), p.117-125

2023

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

En dos antibiotika lika effektiv vid bröstimplantatkirurgi

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy

Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial

High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial

Breast Cancer Survival in Relation to the Metastatic Tumor Burden in Axillary Lymph Nodes

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

3370: Is less axillary surgery safe in irradiated, high-risk breast cancer patients: Results from the SENOMAC trial

Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project

Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases – an open, multicentre, randomised non-inferiority phase 3 trial

Which real indications remain for mastectomy?

Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients

Immediate Breast Reconstruction

Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women

Patients’ experiences of axillary surgery in the randomized SENOMAC trial: a focus group study

Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women

Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy

Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant

CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment

Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom

Medical and surgical postoperative complications after breast conservation versus mastectomy in older women with breast cancer: Swedish population-based register study of 34 139 women

Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom

Abstract P1-01-16: Perspectives on axillary management after primary systemic treatment: An international EUBREAST survey

Axillary staging in node-positive breast cancer converting to node negativity through neoadjuvant chemotherapy: Current evidence and perspectives

Suchergebnisse filtern